With the announcement of Metal Gear Solid: Master Collection Vol. 2 last week and its upcoming release this August, Konami ...

Zydus Lifesciences launches Anyra, India’s first indigenous biosimilar of Aflibercept, aiming to enhance affordable access to advanced diabetic eye-care treatments and strengthen the country’s ...

The IMMUNEBOOST-HPV trial investigated whether adding nivolumab (Opdivo) immunotherapy before standard chemoradiation could improve outcomes for patients with high-risk oropharyngeal cancer. Although ...

First ever successful demonstration of superiority in an FDA-aligned wet AMD trial comparing a novel investigative agent to an approved anti-VEGF treatment ...

Classic cola gets a gut-friendly makeover with these buzzy prebiotic sodas. From stevia-heavy flops to legit sips, here's what actually tastes like cola.

The FDA accepted the new drug application for iberdomide based on minimal residual disease negativity benefit shown in the ...

The FDA granted orphan drug designation to deupirfenidone, also known as LYT-100, for treating patients with idiopathic pulmonary fibrosis, according to a press release from PureTech Health.The ...

Deupirfenidone, a potential new treatment for idiopathic pulmonary fibrosis, is set to be tested in a phase 3 trial this year after a successful phase 2b trial and meeting with the FDA, according to a ...

JSW Group is planning to drive into a market dominated by Maruti Suzuki, one in which Hyundai is a distant second, and one in which the top four companies make four out of five vehicles. But founder ...

Compass Pathways is rated a Hold due to high risk, funding needs, and the need for further data before reassessing the thesis. Read more on CMPS stock here.

Dupilumab was safe and effective for the treatment of patients with severe AD who were aged 6 months to 5 years in a real-world study.

With the EPA launching a new toxicity review and the MAHA movement claiming fluoride is a hidden health menace, the battle lines are being redrawn between public health orthodoxy and rising political ...